Trial Profile
Late lumen loss after treatment of coronary bifurcation lesions with a drug-eluting balloon in patients with symptomatic ischemic heart disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms BIOLUX-I
- Sponsors BIOTRONIK
- 06 Mar 2014 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 27 Apr 2011 New trial record